Brief: Sunesis Announces Pricing Of $12 Mln Offering Of Common Stock
July 29 (Reuters) - Sunesis Pharmaceuticals Inc SNSS.O :
* SUNESIS ANNOUNCES PRICING OF $12 MILLION OFFERING OF
COMMON
STOCK
* SUNESIS PHARMACEUTICALS INC - PRICING OF 52.2 MILLION
SHARES AT
$0.23 PER SHARE
Source text for Eikon: ID:nGNXbhkSpX
Further company coverage: SNSS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update